Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Groupon Inc (GRPN) Stock Is Ready for a Comeback

By Chris Lau, InvestorPlace Contributor

When Groupon reports fourth-quarter results, GRPN stock could rally if it reports that seasonal strength is once again boosting revenue.

Is Micron Technology, Inc. (MU) Stock Really Worth $35?

By Chris Lau, InvestorPlace Contributor

MU stock's upgrade is late, but shares are worth at least $30 a share. Micron stock is worth even more if the memory super-cycle plays out.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Will the Slump End?

By Chris Lau, InvestorPlace Contributor

The flood of Teva Pharmaceutical's (TEVA) bad news, such as a CEO departure and patent case loses, just keep pummeling TEVA stock.

Why Advanced Micro Devices, Inc. (AMD) Stock Will Hit $15 Soon

By Chris Lau, InvestorPlace Contributor

Advanced Micro Devices is just one month away from launching Ryzen. When it does, AMD stock may breakout to new highs and past $15 a share.

BlackBerry Ltd (BBRY) Stock Worth $8 a Share

By Chris Lau, InvestorPlace Contributor

BlackBerry is releasing a BBM software development kit. This is a necessary step as BBRY stock moves toward being more of a software company.

Load More